Publicação
Multiple sclerosis relapse incomplete recovery and associated factors – a systematic review and meta-analysis
| Resumo: | Objectives: We conducted a meta-analysis to assess the frequency of incomplete recovery from multiple sclerosis (MS) relapses and a systematic review to evaluate the influence of six factors on incomplete recovery: relapse severity, age, sex, disease duration, disease-modifying treatment use, and the presence of contrast-enhancing lesions at relapse. Methods: We searched Scientific databases to identify suitable publications. Our outcome was MS relapse incomplete recovery, defined as a post-relapse EDSS measured at least 6 months after the event higher than the pre-relapse EDSS. We synthesized the rate of incomplete recovery using meta-analysis (random effect model). and summarized the effect estimates (or HR) for demographic and clinical factors. Results: We included 13 studies (with a total of 19,920 patients and 27672 relapses having at least six month of follow up). The pooled rate of incomplete recovery was 0.42 (95 % confidence interval 0.31 to 0.54). The subgroup systematic review identified that relapse severity was the most consistent and strongest predictor of incomplete recovery, with odds ratios ranging from 2.4 to 17.2. Other factors were less consistently associated with relapse recovery. |
|---|---|
| Autores principais: | Ladeira, Filipa |
| Outros Autores: | Ladeira, Filipa; Soares, Mafalda; Faustino, Patrícia; Leal Rato, Miguel; Gomes, Inês; Caetano, André; Taipa, Ricardo; Sá, Maria José |
| Assunto: | Disability Multiple sclerosis Relapse associated disability (RAW) Relapse recovery Neurology Clinical Neurology |
| Ano: | 2025 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
Registos relacionados
article REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
por: Batista, S
Publicado em: (2020)
por: Batista, S
Publicado em: (2020)
article Natural history of relapsing remitting multiple sclerosis in a long-lasting cohort from a tertiary MS centre in Portugal
por: Sá, Maria José
Publicado em: (2021)
por: Sá, Maria José
Publicado em: (2021)
article Smouldering multiple sclerosis: the 'real MS'
por: Giovannoni, Gavin
Publicado em: (2022)
por: Giovannoni, Gavin
Publicado em: (2022)
article REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
por: Batista, S.
Publicado em: (2021)
por: Batista, S.
Publicado em: (2021)
text_fields Multiple Sclerosis Relapse Incomplete Recovery and Associated Factors - a Systematic Review and Meta-Analysis.
por: Ladeira, Filipa
Publicado em: (2025)
por: Ladeira, Filipa
Publicado em: (2025)
article Multiple Sclerosis Disease-Modifying Treatment Algorithms
por: Capela, Carlos
Publicado em: (2025)
por: Capela, Carlos
Publicado em: (2025)
article Charcot-Marie-Tooth Type 2 Disease and Relapsing Remitting Multiple Sclerosis Coexistence
por: Marques, Ana João
Publicado em: (2024)
por: Marques, Ana João
Publicado em: (2024)
article REALMS Study: Real-World Effectiveness and Safety of Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis in Portugal
por: Batista, S
Publicado em: (2021)
por: Batista, S
Publicado em: (2021)
article A Multicenter, Non-Interventional Study to Evaluate the Disease Activity in Multiple Sclerosis after Withdrawal of Natalizumab in Portugal
por: Ladeira, F
Publicado em: (2019)
por: Ladeira, F
Publicado em: (2019)
school Efetividade da Reabilitação Motora na Pessoa com Esclerose Múltipla, Após um Surto
por: Ribeiro, Liliana de Fátima Escada
Publicado em: (2019)
por: Ribeiro, Liliana de Fátima Escada
Publicado em: (2019)
article Interferon-beta treated-multiple sclerosis patients exhibit a decreased ratio between immature/transitional B cell subset and plasmablasts
por: Monteiro, Andreia
Publicado em: (2018)
por: Monteiro, Andreia
Publicado em: (2018)
article Serum 25-hydroxyvitamin D levels in multiple sclerosis patients from the north of Portugal
por: Bettencourt, Andreia
Publicado em: (2017)
por: Bettencourt, Andreia
Publicado em: (2017)
text_fields The Role of Disease Modifying Therapies in Late-Onset Multiple Sclerosis: A Portuguese Multicentric Characterization Study.
por: Faustino, Patrícia
Publicado em: (2024)
por: Faustino, Patrícia
Publicado em: (2024)
article Multiple Sclerosis Disease-Modifying Treatment Algorithms: 2025 Positioning of the Portuguese Multiple Sclerosis Study Group
por: Capela, Carlos
Publicado em: (2025)
por: Capela, Carlos
Publicado em: (2025)
assignment Fatal Tracheal Stenosis in Relapsing Polychondritis
por: Ambrozino,Luiza Carvalho
Publicado em: (2026)
por: Ambrozino,Luiza Carvalho
Publicado em: (2026)
article TyPed study
por: Palavra, Filipe
Publicado em: (2021)
por: Palavra, Filipe
Publicado em: (2021)
article Inflammatory Activity and Treatment Response in Pediatric Compared to Adult Multiple Sclerosis: A Pilot, Retrospective and Observational Study of the First Year After Diagnosis
por: de Carvalho, Sara
Publicado em: (2021)
por: de Carvalho, Sara
Publicado em: (2021)
article Treatment of relapsing polychondritis: a systematic review
por: Petitdemange, Arthur
Publicado em: (2022)
por: Petitdemange, Arthur
Publicado em: (2022)
school Biologic therapies for cancer treatment : insights on immunotherapies targeting relapsed/refractory multiple myeloma
por: Pereira, Patrícia Marina Mendonça
Publicado em: (2023)
por: Pereira, Patrícia Marina Mendonça
Publicado em: (2023)
article Book review: Relapse prevention counseling workbook
por: Trigo, Miguel
Publicado em: (2006)
por: Trigo, Miguel
Publicado em: (2006)
article Clinical findings in 67 patients with tuberous sclerosis
por: Fernández-Guarino, M
Publicado em: (2009)
por: Fernández-Guarino, M
Publicado em: (2009)
article Relapsing risk factors in polyaddictions: is also about positive emotions
por: Santos,Rodrigo
Publicado em: (2021)
por: Santos,Rodrigo
Publicado em: (2021)
mic FELINE RENAL CHRONIC DISEASE: A RETROSPECTIVE STUDY OF THE SERUM CREATINE VALUE IN THE FIRST EPISODE OF HOSPITALIZATION, AS A PREDICTIVE VALUE FOR RELAPSE
por: Rodrigues, Maria João
Publicado em: (2023)
por: Rodrigues, Maria João
Publicado em: (2023)
assignment Cerebral vasculitis - a rare presentation of antineutrophil cytoplasmic antibody associated vasculitis relapse
por: Rodrigues,Sara Daniela
Publicado em: (2019)
por: Rodrigues,Sara Daniela
Publicado em: (2019)
article The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study
por: Sousa, L.
Publicado em: (2014)
por: Sousa, L.
Publicado em: (2014)
article Effectiveness of Mindfulness-Based Relapse Prevention in Individuals with Substance Use Disorders: A Systematic Review
por: Ramadas, E.
Publicado em: (2021)
por: Ramadas, E.
Publicado em: (2021)
article Effectiveness of Mindfulness-Based Relapse Prevention in Individuals with Substance Use Disorders: A Systematic Review
por: Ramadas, Eduardo
Publicado em: (2021)
por: Ramadas, Eduardo
Publicado em: (2021)
groups European Portuguese Version of the Stimulant Relapse Risk Scale (SRRS): Preliminary psychometric characterization
por: Dias, Joana Andreia
Publicado em: (2023)
por: Dias, Joana Andreia
Publicado em: (2023)
article The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study
por: Sousa, L.
Publicado em: (2014)
por: Sousa, L.
Publicado em: (2014)
school Relapsing meningoencephalomyelitis of unknown origin : neurological presentation, diagnostic clinicopathological findings, imaging characteristics and therapeutic management of dogs with and without relapse
por: Aragão, Ana Rita Vaz de
Publicado em: (2022)
por: Aragão, Ana Rita Vaz de
Publicado em: (2022)
article Relapsed Ovarian Cancer patients with ascites and/or pleural effusion still benefit from treatment: A real-life study
por: Rebordão-Pires, Mariana
Publicado em: (2023)
por: Rebordão-Pires, Mariana
Publicado em: (2023)
article Analysis of a SIRI epidemic model with distributed delay and relapse
por: Elazzouzi, Abdelhai
Publicado em: (2019)
por: Elazzouzi, Abdelhai
Publicado em: (2019)
school Profiling and relapse prediction of breast cancer patients
por: Vieira, Bruno André Rebelo
Publicado em: (2022)
por: Vieira, Bruno André Rebelo
Publicado em: (2022)
article Metadherin expression and lung relapse in patients with colorectal carcinoma
por: Casimiro, Sandra
Publicado em: (2014)
por: Casimiro, Sandra
Publicado em: (2014)
article Growing evidence supporting the use of mesenchymal stem cell therapies in multiple sclerosis: a systematic review
por: Oliveira, Ana Gabriela
Publicado em: (2020)
por: Oliveira, Ana Gabriela
Publicado em: (2020)
article Long-term follow-up of subthalamic nucleus deep brain stimulation in patients with Parkinson's disease
por: Barbosa, Raquel
Publicado em: (2024)
por: Barbosa, Raquel
Publicado em: (2024)
school Estimation of relapse probability in early stages non-small cell lung cancer patients
por: Pardal, Mariana Raimundo
Publicado em: (2022)
por: Pardal, Mariana Raimundo
Publicado em: (2022)
article Predictive Factors of Relapse After Methotrexate Discontinuation in Juvenile Idiopathic Arthritis Patients With Inactive Disease
por: Azevedo, S
Publicado em: (2022)
por: Azevedo, S
Publicado em: (2022)
article Relapse after Orthodontic-Surgical Treatment: A Retrospective Longitudinal Study
por: Matos, João
Publicado em: (2023)
por: Matos, João
Publicado em: (2023)
article Rare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis
por: Damian, Laura
Publicado em: (2022)
por: Damian, Laura
Publicado em: (2022)
Registos relacionados
-
article REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
por: Batista, S
Publicado em: (2020) -
article Natural history of relapsing remitting multiple sclerosis in a long-lasting cohort from a tertiary MS centre in Portugal
por: Sá, Maria José
Publicado em: (2021) -
article Smouldering multiple sclerosis: the 'real MS'
por: Giovannoni, Gavin
Publicado em: (2022) -
article REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
por: Batista, S.
Publicado em: (2021) -
text_fields Multiple Sclerosis Relapse Incomplete Recovery and Associated Factors - a Systematic Review and Meta-Analysis.
por: Ladeira, Filipa
Publicado em: (2025)